Targeted Medical Pharma Stock Price, News & Analysis (OTCMKTS:TRGM)

$0.03 0.00 (0.00 %)
(As of 01/17/2018 03:17 AM ET)
Previous Close$0.03
Today's RangeN/A
52-Week Range$0.01 - $0.03
VolumeN/A
Average Volume6,511 shs
Market Capitalization$754,640.00
P/E Ratio-0.23
Dividend YieldN/A
Beta114.13

About Targeted Medical Pharma (OTCMKTS:TRGM)

Targeted Medical Pharma, Inc. (TMP), also doing business as Physician Therapeutics (PTL), is a specialty pharmaceutical company that develops and commercializes amino acid-based medications. The Company develops and distributes a line of amino acid-based medical food products, dietary supplements and generic drugs to physicians, pharmacies and patients throughout the United States and abroad. The Company operates through TMP, Complete Claims Processing Inc. (CCPI) and Amino Nutritionals segments. TMP develops and distributes amino acid-based therapeutic products and distributes pharmaceutical products from other manufacturers. CCPI segment provides point-of-care dispensing solutions, and billing and collections services. Amino Nutritionals segment develops and distributes amino acid-based dietary supplements directly to consumers. Its products and services include Medical Foods, Medical foods and generic pharmaceuticals, and Billing and Collections.

Receive TRGM News and Ratings via Email

Sign-up to receive the latest news and ratings for TRGM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drugs - Generic
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:TRGM
CUSIPN/A
Phone+1-310-4749809

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-0.227272727272727
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares30,190,000

Targeted Medical Pharma (OTCMKTS:TRGM) Frequently Asked Questions

What is Targeted Medical Pharma's stock symbol?

Targeted Medical Pharma trades on the OTCMKTS under the ticker symbol "TRGM."

Who are some of Targeted Medical Pharma's key competitors?

Who are Targeted Medical Pharma's key executives?

Targeted Medical Pharma's management team includes the folowing people:

  • Marcus Charuvastra, Interim Chief Executive Officer, Director
  • William B. Horne, Chief Financial Officer (Age 49)
  • Kim Giffoni, Executive Vice President - Foreign Sales, Director (Age 64)
  • Douglas P Gintz, Chief Technology Officer (Age 49)
  • David Samuel Silver M.D., Chief Medical Officer, Director (Age 49)
  • Kerry N. Weems, Non-Executive Chairman of the Board, Director (Age 58)
  • Maurice J. DeWald, Independent Director (Age 77)
  • Thomas Wenkart, Independent Director (Age 71)

How do I buy Targeted Medical Pharma stock?

Shares of Targeted Medical Pharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Targeted Medical Pharma's stock price today?

One share of Targeted Medical Pharma stock can currently be purchased for approximately $0.03.

How big of a company is Targeted Medical Pharma?

Targeted Medical Pharma has a market capitalization of $754,640.00.

How can I contact Targeted Medical Pharma?

Targeted Medical Pharma's mailing address is 2980 N Beverly Glen Cir Ste 301, LOS ANGELES, CA 90077-1735, United States. The specialty pharmaceutical company can be reached via phone at +1-310-4749809 or via email at [email protected]


MarketBeat Community Rating for Targeted Medical Pharma (TRGM)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  12 (Vote Outperform)
Underperform Votes:  11 (Vote Underperform)
Total Votes:  23
MarketBeat's community ratings are surveys of what our community members think about Targeted Medical Pharma and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Targeted Medical Pharma (OTCMKTS:TRGM) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Targeted Medical Pharma (OTCMKTS:TRGM) Earnings History and Estimates Chart

Earnings by Quarter for Targeted Medical Pharma (OTCMKTS:TRGM)

Targeted Medical Pharma (OTCMKTS TRGM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/13/2015Q3 2015($0.01)ViewN/AView Earnings Details
8/14/2015Q2 2015($0.02)ViewN/AView Earnings Details
5/15/2015Q1 2015($0.06)ViewN/AView Earnings Details
4/15/2015Q4 2014($0.06)ViewN/AView Earnings Details
11/14/2014Q3 2014($0.04)ViewN/AView Earnings Details
8/14/2014Q2 2014($0.02)($0.02)ViewN/AView Earnings Details
5/21/2014Q1 2014($0.02)($0.04)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Targeted Medical Pharma (OTCMKTS:TRGM) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Targeted Medical Pharma (OTCMKTS:TRGM)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Targeted Medical Pharma (OTCMKTS TRGM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 69.20%
Insider Trades by Quarter for Targeted Medical Pharma (OTCMKTS:TRGM)

Targeted Medical Pharma (OTCMKTS TRGM) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/24/2015Kim GiffoniCEOSell8,580$0.02$171.60View SEC Filing  
5/28/2014William ShellCEOSell2,000$0.60$1,200.00View SEC Filing  
5/27/2014William ShellCEOSell3,000$0.65$1,950.00View SEC Filing  
4/10/2014William ShellCEOSell150,000$0.60$90,000.00View SEC Filing  
4/9/2014Kim GiffoniEVPBuy5,000$0.83$4,150.00View SEC Filing  
12/12/2013Kim GiffoniEVPBuy1,000$0.90$900.00View SEC Filing  
12/11/2013Kim GiffoniEVPBuy11,980$0.88$10,542.40View SEC Filing  
12/2/2013Kim GiffoniEVPBuy4,800$1.06$5,088.00View SEC Filing  
9/13/2013William ShellDirectorSell2,000$0.84$1,680.00View SEC Filing  
6/20/2013William ShellDirectorBuy28,100$1.15$32,315.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Targeted Medical Pharma (OTCMKTS TRGM) News Headlines

Source:

SEC Filings

Targeted Medical Pharma (OTCMKTS:TRGM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Targeted Medical Pharma (OTCMKTS TRGM) Stock Chart for Wednesday, January, 17, 2018

Loading chart…

This page was last updated on 1/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.